| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 21, 2007
Accepted on January 8, 2008
phosphorylates Insulin Receptor Substrate-1, -3, and -4, but not -2: isoform specific determinants of specificity in insulin signaling
Diabetes Unit, National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethesda, Maryland, 20892
* To whom correspondence should be addressed. E-mail: quonm{at}nih.gov.
Protein Kinase C-
(PKC-
), a downstream effector of phosphatidylinositol 3-kinase (PI3K), phosphorylates insulin receptor substrate 1 (IRS-1) on serine residues impairing activation of PI3K in response to insulin. Since IRS-1 is upstream from PI3K, this represents a negative feedback mechanism that may contribute to signal specificity in insulin action. To determine if similar feedback pathways exist for other IRS isoforms, we evaluated IRS-2, -3, and -4 as substrates for PKC-
. In an in vitro kinase assay, purified recombinant PKC-
phosphorylated IRS-1, -3 and -4, but not IRS-2. Similar results were obtained with an immune-complex kinase assay demonstrating that wild-type, but not kinase-deficient mutant PKC-
, phosphorylated IRS-1, -3, and -4, but not IRS-2. We evaluated functional consequences of serine phosphorylation of IRS isoforms by PKC-
in NIH-3T3IR cells co-transfected with epitope-tagged IRS proteins and either PKC-
or empty vector control. Insulin-stimulated IRS tyrosine phosphorylation was impaired by overepxression of PKC-
for IRS-1, -3, and -4, but not IRS-2. Significant insulin-stimulated increases in PI3K activity was co-immunoprecipitated with all IRS isoforms. In cells overexpressing PKC-
there was marked inhibition of insulin-stimulated PI3K activity associated with IRS-1, -3 and -4, but not IRS-2. That is, PI3K activity associated with IRS-2 in response to insulin was similar in control cells and cells overexpressing PKC-
. We conclude that IRS-3 and -4 are novel substrates for PKC-
that may participate in a negative feedback pathway for insulin signaling similar to IRS-1. The inability of PKC-
to phosphorylate IRS-2 may help determine specific functional roles for IRS-2.
IRS-1
Insulin Signaling
Negative Feedback
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |